Showing 2061-2070 of 10609 results for "".
Take a Load Off Your Back: A How-To Guide
https://practicaldermatology.com/topics/practice-management/take-a-load-off-your-back-a-how-to-guide/22076/Dermatologic surgeons spend their days bent over exam tables to perform procedures. Their backs may suffer.Bed Bug Infestations
https://practicaldermatology.com/topics/practice-management/bed-bug-infestations/21099/Expert insights from DermTube for diagnosing and treating the symptoms of bites, and on how to eradicate the bugs.We Care: Ten Tips on Building Patient Rapport
https://practicaldermatology.com/topics/practice-management/we-care-ten-tips-on-building-patient-rapport/22908/Relationships should be nurtured by anyone with whom patients have contact during their visit.What to Know About PA Education and Dermatology Training
https://practicaldermatology.com/topics/general-topics/what-to-know-about-pa-education-and-dermatology-training/21643/Part II of a series highlights key considerations regarding the education and training of PAs in dermatology.An Overview of Topical Therapies for Managing Pediatric AD
https://practicaldermatology.com/topics/atopic-dermatitis/an-overview-of-topical-ththerapies-for-managing-pediatric-ad/54375/Moisturization is foundational in AD management; no specific formulation has demonstrated superiority, and excessive bathing may worsen disease via increased transepidermal water loss. Topical corticosteroids and calcineurin inhibitors remain first-line due to strong efficacy data, cost-effectiveneExperts React to Latest Benzene Analysis
https://practicaldermatology.com/series/dermwire-tv/experts-react-to-latest-benzene-analysis/29810/In this week's DermwireTV, Practical Dermatology Editorial Board members provide their thoughts on the recent analysis examining benzene concentrations in BPO products; Johnson & Johnson seeks new indications for IL-23 inhibitor Tremfya; and the founder and CEO of Terns discusses plans to improvVerrucous Psoriasis
https://practicaldermatology.com/topics/psoriasis/verrucous-psoriasis/27148/Verrucous psoriasis (VP) is a rare subtype of psoriasis most commonly affecting middle-aged to older adults, with fewer than 35 reported cases within the current literature. It is characterized by symmetric wart-like, hyperkeratotic, papillomatous plaques. Treatment options are limited and variable,Current and Future Treatments
https://practicaldermatology.com/series/updates-vitiligo/current-and-future-treatments/26622/Dr. Karan Lal, a double board-certified adult and pediatric dermatologist and fellowship-trained cosmetic dermatologist with Affiliated Dermatology in Scottsdale, Arizona, talks with Practical Dermatology about the various options available today for repigmentation and treating flare-ups in vitiligoCan You Afford to Opt Out of Medicare?
https://practicaldermatology.com/topics/practice-management/can-you-afford-to-opt-out-of-medicare/23884/What to consider when making the the decision and the steps to take.Evaluation of Cosmetic Training in Dermatology Residency
https://practicaldermatology.com/youngmd-connect/resident-resource-center/evaluation-of-cosmetic-training-in-dermatology-residency/23670/Survey findings highlight the need to expand cosmetic training in US residency programs.